Related Experiment Video

Updated: Jun 17, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Prevention and treatment of microvascular disease in childhood type 1 diabetes

M L Marcovecchio1, P H Tossavainen, D B Dunger

  • 1Department of Paediatrics and Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

British Medical Bulletin
|January 8, 2010
PubMed

Insights

The global rise in type 1 diabetes (T1D) in children necessitates early intervention for microvascular complications. Improving glycemic control is key, but specific treatments for pediatric T1D complications require further research.

Area of Science:

  • Endocrinology
  • Diabetology
  • Pediatrics

Background:

  • Type 1 diabetes (T1D) incidence is rising globally, especially in children.
  • T1D poses a significant health burden due to vascular complications like nephropathy, retinopathy, and neuropathy.
  • Preventing and treating these microvascular complications is crucial for reducing mortality and morbidity.

Purpose of the Study:

  • To review the implications of increasing childhood T1D incidence on the prevention and treatment of microvascular complications.
  • To highlight the importance of early identification and intervention strategies for at-risk individuals.

Main Methods:

  • A literature search was conducted on Medline.
  • Articles focusing on microvascular complications in T1D were selected, with emphasis on childhood T1D.

Main Results:

  • Childhood T1D incidence is increasing, underscoring the need for early management of complications.
  • Optimal glycemic control is the primary strategy for preventing and treating T1D-related microvascular issues.
  • While antihypertensives and statins are used in adults, their role in children with early complications is not yet defined.

Conclusions:

  • New strategies targeting specific pathogenic pathways for microvascular complications are under development.
  • Further research into genetic and environmental factors may identify predictive biomarkers for screening and intervention programs.
Abstract

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...